297 related articles for article (PubMed ID: 15717063)
1. Neuroprotection in experimental stroke with targeted neurotrophins.
Wu D
NeuroRx; 2005 Jan; 2(1):120-8. PubMed ID: 15717063
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins.
Pardridge WM
Adv Exp Med Biol; 2002; 513():397-430. PubMed ID: 12575830
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophins, neuroprotection and the blood-brain barrier.
Pardridge WM
Curr Opin Investig Drugs; 2002 Dec; 3(12):1753-7. PubMed ID: 12528312
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.
Zhang Y; Pardridge WM
Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
Zhang Y; Pardridge WM
Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
[TBL] [Abstract][Full Text] [Related]
6. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector.
Song BW; Vinters HV; Wu D; Pardridge WM
J Pharmacol Exp Ther; 2002 May; 301(2):605-10. PubMed ID: 11961063
[TBL] [Abstract][Full Text] [Related]
7. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice.
Kilic U; Kilic E; Dietz GP; Bähr M
Stroke; 2003 May; 34(5):1304-10. PubMed ID: 12677018
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection with noninvasive neurotrophin delivery to the brain.
Wu D; Pardridge WM
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):254-9. PubMed ID: 9874805
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches.
Sharma HS; Johanson CE
Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568
[TBL] [Abstract][Full Text] [Related]
10. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
[TBL] [Abstract][Full Text] [Related]
11. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide.
Fu A; Wang Y; Zhan L; Zhou R
Pharm Res; 2012 Jun; 29(6):1562-9. PubMed ID: 22231987
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
Wu D; Song BW; Vinters HV; Pardridge WM
J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
[TBL] [Abstract][Full Text] [Related]
14. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
Pardridge WM; Kang YS; Buciak JL
Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
[TBL] [Abstract][Full Text] [Related]
15. A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury.
Sharma HS
Ann N Y Acad Sci; 2007 Dec; 1122():95-111. PubMed ID: 18077567
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
[TBL] [Abstract][Full Text] [Related]
17. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
Fukuta T; Ishii T; Asai T; Oku N
Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia].
Yang J; Zhao ZH; Qian YH; Hu XD; Li M; Zong CH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1801-4. PubMed ID: 18158987
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems for the treatment of ischemic stroke.
Rhim T; Lee DY; Lee M
Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats.
Yang J; Song TB; Zhao ZH; Qiu SD; Hu XD; Chang L
Brain Res; 2011 Jun; 1398():94-101. PubMed ID: 21620378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
